Trade Mark Journal No.2026/020 15 May 2026

UK00004379991 28 April 2026 (5)

Intestisol

Class 5: Pharmaceutical products; prescription only medicine for the management of electyle loss in patients with high stoma output or short bowel syndrome .

KORA CORPORATION LIMITED

Representative: Maclachlan IP